Guru Ownership Trend
Guru Analysis for Vir Biotechnology, Inc. (VIR)
Vir Biotechnology, Inc. (VIR), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $29.51 M.
Top institutional holders include Steven Cohen and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $20.5 M net inflow during the quarter.
Recent activity highlights Steven Cohen who increased their stake by 897.5%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Vir Biotechnology, Inc. (VIR)
Major holders include Steven Cohen ($17.49 M), Renaissance Technologies (RenTech) ($6.82 M), Cliff Asness ($5.07 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 3.35 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $20.5 M, with 4 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in VIR during the most recent reporting period.
Yes, 0 managers opened new positions in VIR, and 4 increased their existing holdings. The total reported buy value was $20.5 M.